Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02698670 · ClinicalTrials.gov registry record
Prospective Registry on User Experience With The Mapping System For Ablation Procedures
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 577
- Enrollment target
NCT02698670 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 577 participants.
The verdict
NCT02698670 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 577 participants
- Enrollment target
Study Summary
This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.
Interventions
- DEVICE Rhythmia mapping system
- DEVICE IntellaMap Orion mapping catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 577 participants |
| Start Date | 2016-05-25 |
| Est. Completion | 2017-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02698670
The ClinicalTrials.gov registry entry for NCT02698670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 577 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rhythmia mapping system is the first listed.
NCT02698670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02698670 about?
NCT02698670 is a clinical study titled "Prospective Registry on User Experience With The Mapping System For Ablation Procedures". This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.
What is the current status of trial NCT02698670?
This trial is currently completed. The enrollment target is 577 participants. The study started on 2016-05-25. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02698670?
The interventions under investigation include: Rhythmia mapping system (DEVICE), IntellaMap Orion mapping catheter (DEVICE).
Who is sponsoring clinical trial NCT02698670?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.